{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:58:58Z","timestamp":1785891538090,"version":"3.56.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T00:00:00Z","timestamp":1681084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T00:00:00Z","timestamp":1681084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"crossref","award":["18JC1414200"],"award-info":[{"award-number":["18JC1414200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81972891"],"award-info":[{"award-number":["81972891"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81972392"],"award-info":[{"award-number":["81972392"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Doxorubicin (Dox) has been recommended in clinical guidelines for the standard-of-care treatment of breast cancer. However, Dox therapy faces challenges such as hypoxia, acidosis, H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub>-rich conditions and condensed extracellular matrix in TME as well as low targeted ability.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We developed a nanosystem H-MnO<jats:sub>2<\/jats:sub>-Dox-Col NPs based on mesoporous manganese dioxide (H-MnO<jats:sub>2<\/jats:sub>) in which Dox was loaded in the core and collagenase (Col) was wrapped in the surface. Further the H-MnO<jats:sub>2<\/jats:sub>-Dox-Col NPs were covered by a fusion membrane (MP) of inflammation-targeted RAW264.7 cell membrane and pH-sensitive liposomes to form biomimetic MP@H-MnO<jats:sub>2<\/jats:sub>-Dox-Col for <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our results shows that MP@H-MnO<jats:sub>2<\/jats:sub>-Dox-Col can increase the Dox effect with low cardiotoxicity based on multi-functions of effective penetration in tumor tissue, alleviating hypoxia in TME, pH sensitive drug release as well as targeted delivery of Dox.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This multifunctional biomimetic nanodelivery system exhibited antitumor efficacy <jats:italic>in vivo<\/jats:italic> and <jats:italic>in vitro<\/jats:italic>, thus having potential for the treatment of breast cancer.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12951-023-01874-7","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T04:02:57Z","timestamp":1681099377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Biomimetic liposomal nanozymes improve breast cancer chemotherapy with enhanced penetration and alleviated hypoxia"],"prefix":"10.1186","volume":"21","author":[{"given":"Juanjuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunai","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanhuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongguang","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,10]]},"reference":[{"issue":"1","key":"1874_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KDM, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"key":"1874_CR2","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1016\/j.ejca.2008.09.025","volume":"4","author":"M Milani","year":"2008","unstructured":"Milani M, Harris AL. Targeting tumour hypoxia in breast cancer. Eur J Cancer. 2008;4:2766\u201373.","journal-title":"Eur J Cancer"},{"key":"1874_CR3","doi-asserted-by":"publisher","first-page":"626229","DOI":"10.3389\/fcell.2021.626229","volume":"9","author":"M Tang","year":"2021","unstructured":"Tang M, Bolderson E, O\u2019Byrne KJ, Richard DJ. Tumor hypoxia drives genomic instability. Front Cell Dev Biol. 2021;9:626229.","journal-title":"Front Cell Dev Biol"},{"key":"1874_CR4","doi-asserted-by":"crossref","unstructured":"Zhu XH, Du JX, Zhu D, Ren SZ, Chen K, Zhu HL. Recent research on methods to improve tumor hypoxia environment. Oxid Med Cell Longev. 2020; 2020: 5721258.","DOI":"10.1155\/2020\/5721258"},{"key":"1874_CR5","doi-asserted-by":"crossref","unstructured":"Qian C, Yu J, Chen Y, Hu Q, Xiao X, Sun W, Wang C. FengP., SheQ., GuZ., Light-activated hypoxia-responsive nanocarriers for enhanced anticancer therapy. Adv Mater. 2016; 28: 3313\u20133320.","DOI":"10.1002\/adma.201505869"},{"key":"1874_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s13046-021-02000-x","volume":"40","author":"I Telarovic","year":"2021","unstructured":"Telarovic I, Wenger RH, Pruschy M. Interfering with tumor hypoxia for radiotherapy optimization. J Exp Clin Cancer Res. 2021;40:197.","journal-title":"J Exp Clin Cancer Res"},{"key":"1874_CR7","doi-asserted-by":"crossref","unstructured":"Ping Y, Deng FA, Liu YB, Zheng RR, Rao XN, Qiu XZ. ZhangD., YuX., ChengH., LiS., Mitochondria targeted O2economizer to alleviate tumor hypoxia for enhanced photodynamic therapy. Adv Healthc Mater. 2021; 10: e2100198.","DOI":"10.1002\/adhm.202100198"},{"key":"1874_CR8","doi-asserted-by":"publisher","first-page":"120847","DOI":"10.1016\/j.biomaterials.2021.120847","volume":"273","author":"J Liu","year":"2021","unstructured":"Liu J, Ai X, Cabral H, Liu J, Huang Y, Mi P. Tumor hypoxia-activated combinatorial nanomedicine triggers systemic antitumor immunity to effectively eradicate advanced breast cancer. Biomaterials. 2021;273:120847.","journal-title":"Biomaterials"},{"key":"1874_CR9","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1582-4934.2009.00994.x","volume":"14","author":"J Chiche","year":"2010","unstructured":"Chiche J, Brahimi-Horn MC, Pouyss\u00e9gur J. Tumour hypoxia induces a metabolic shift causing acidosis: acommon feature in cancer. J Cell Mol Med. 2010;14:771\u201394.","journal-title":"J Cell Mol Med"},{"key":"1874_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2006.10.029","volume":"252","author":"M L\u00f3pez-L\u00e1zaro","year":"2007","unstructured":"L\u00f3pez-L\u00e1zaro M. Dual role of Hydrogen Peroxide in Cancer: possible relevance to cancer chemoprovention and therapy. Cancer Lett. 2007;252:1\u20138.","journal-title":"Cancer Lett"},{"issue":"3","key":"1874_CR11","first-page":"288","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks AG, Winer EP. Breast Cancer Treatment: A Review JAMA. 2019;321(3):288\u2013300.","journal-title":"Breast Cancer Treatment: A Review JAMA"},{"key":"1874_CR12","doi-asserted-by":"publisher","first-page":"1064661","DOI":"10.3389\/fphar.2022.1064661","volume":"13","author":"Y Gu","year":"2022","unstructured":"Gu Y, Sun Z, Xiao J, Shen. Targeting hypoxia-inducible factors for breast cancer therapy: a narrative review. Front Pharmacol. 2022;13:1064661.","journal-title":"Front Pharmacol"},{"key":"1874_CR13","doi-asserted-by":"publisher","first-page":"121449","DOI":"10.1016\/j.biomaterials.2022.121449","volume":"283","author":"WL Pan","year":"2022","unstructured":"Pan WL, Tan Y, Meng W, Huang NH, Zhao YB, Yu ZQ, Huang Z, Zhang WH, Sun B, Chen JX. Microenvironment-driven sequential ferroptosis, photodynamic therapy, and chemotherapy for targeted breast cancer therapy by a cancer-cell-membrane-coated nanoscale metal-organic framework. Biomaterials. 2022;283:121449.","journal-title":"Biomaterials"},{"key":"1874_CR14","doi-asserted-by":"publisher","first-page":"8349","DOI":"10.1039\/D2NR00985D","volume":"14","author":"M Wu","year":"2022","unstructured":"Wu M, Chen T, Wang L, Akakuru OU, Ma X, Xu J, Hu J, Chen J, Fang Q, Wu A, Li Q. The strategy of precise targeting and in situ oxygenating for enhanced triple-negative breast cancer chemophototherapy. Nanoscale. 2022;14:8349\u201361.","journal-title":"Nanoscale"},{"key":"1874_CR15","doi-asserted-by":"publisher","first-page":"6145","DOI":"10.1021\/acs.nanolett.6b02365","volume":"16","author":"X Song","year":"2016","unstructured":"Song X, Feng L, Liang C, Yang K, Liu Z. Ultrasound triggered tumor oxygenation with oxygen-shuttle nanoperfluorocarbon to overcome hypoxia-associated resistance in cancer therapies. Nano Lett. 2016;16:6145\u201353.","journal-title":"Nano Lett"},{"key":"1874_CR16","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/adma.201502581","volume":"28","author":"Y Jia","year":"2016","unstructured":"Jia Y, Duan L, Li J. Hemoglobin-based Nanoarchitectonic Assemblies as Oxygen Carriers. Adv Mater. 2016;28:1312\u20138.","journal-title":"Adv Mater"},{"key":"1874_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.biomaterials.2017.05.025","volume":"138","author":"R Zhang","year":"2017","unstructured":"Zhang R, Song X, Liang C, X.i Y, Song G, Chao Y, Yang Y, Yang K, Feng L, Liu Z. Catalase-loaded cisplatin-prodrug-constructed liposomes to overcome tumor hypoxia for enhanced chemo-radiotherapy of cancer. Biomaterials. 2017;138:13\u201321.","journal-title":"Biomaterials"},{"key":"1874_CR18","doi-asserted-by":"publisher","first-page":"4334","DOI":"10.1021\/acs.nanolett.9b00934","volume":"19","author":"X Yang","year":"2019","unstructured":"Yang X, Yang Y, Gao F, Wei JJ, Qian CG, Sun MJ. Biomimetic hybrid nanozymes with self-supplied H+ and accelerated O2 generation for enhanced starvation and photodynamic therapy against hypoxic tumors. Nano Lett. 2019;19:4334\u201342.","journal-title":"Nano Lett"},{"key":"1874_CR19","doi-asserted-by":"publisher","first-page":"112025","DOI":"10.1016\/j.colsurfb.2021.112025","volume":"207","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zhu C, Zhang Z, Zhao J, Yuan Y, Wang S. Oxidation triggered formation of polydopamine-modified carboxymethyl cellulose hydrogel for anti-recurrence of tumor. Colloids Surf B. 2021;207:112025.","journal-title":"Colloids Surf B"},{"key":"1874_CR20","doi-asserted-by":"publisher","first-page":"e1706090","DOI":"10.1002\/adma.201706090","volume":"30","author":"Q Jia","year":"2018","unstructured":"Jia Q, Ge J, Liu W, Zheng X, Chen S, Wen Y, Zhang H, Wang P. A magnetofluorescent carbon dot assembly as an acidic H2O2-driven oxygenerator to regulate tumor hypoxia for simultaneous bimodal imaging and enhanced photodynamic therapy. Adv Mater. 2018;30:e1706090.","journal-title":"Adv Mater"},{"key":"1874_CR21","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1021\/nn405773r","volume":"8","author":"P Prasad","year":"2014","unstructured":"Prasad P, Gordijo CR, Abbasi AZ, Maeda A, Ip A, Rauth AM, DaCosta RS, Wu XY. Multifunctional albumin MnO2 nanoparticles modulate solid tumor microenvironment by attenuating hypoxia, acidosis, vascular endothelial growth factor and enhance radiation response. ACS Nano. 2014;8:3202\u201312.","journal-title":"ACS Nano"},{"key":"1874_CR22","doi-asserted-by":"publisher","first-page":"11000","DOI":"10.1021\/acsnano.8b05042","volume":"12","author":"L Feng","year":"2018","unstructured":"Feng L, Xie R, Wang C, Gai S, He F, Yang D, Yang P, Lin J. Magnetic targeting, tumor microenvironment-responsive intelligent nanocatalysts for enhanced tumor ablation. ACS Nano. 2018;12:11000\u201312.","journal-title":"ACS Nano"},{"key":"1874_CR23","doi-asserted-by":"publisher","first-page":"1702664","DOI":"10.1002\/smll.201702664","volume":"14","author":"G Yang","year":"2018","unstructured":"Yang G, Zhang R, Liang C, Zhao H, Yi X, Shen S, Yang K, Cheng L, Liu Z. Manganese dioxide coated WS2@Fe3O4\/sSiO2 nanocomposites for pH-responsive MR imaging and oxygen-elevated synergetic therapy. Small. 2018;14:1702664.","journal-title":"Small"},{"key":"1874_CR24","doi-asserted-by":"publisher","first-page":"44407","DOI":"10.1021\/acsami.0c08473","volume":"12","author":"CC Chang","year":"2020","unstructured":"Chang CC, Dinh TK, Lee YA, Wang FN, Sung YC, Yu PL, Chiu S, Shih Y, Wu C, Huang Y, Wang J, Lu T, Wan D, Chen Y. Nanoparticle delivery of MnO2 and antiangiogenic therapy to overcome hypoxia-driven tumor escape and suppress hepatocellular carcinoma. ACS Appl Mater Inter. 2020;12:44407\u201319.","journal-title":"ACS Appl Mater Inter"},{"key":"1874_CR25","doi-asserted-by":"publisher","first-page":"7065","DOI":"10.1039\/D0CC02782K","volume":"56","author":"J Wen","year":"2020","unstructured":"Wen J, Yang K, Sun S. MnO2-Based nanosystems for cancer therapy. Chem Commun. 2020;56:7065\u201379.","journal-title":"Chem Commun"},{"key":"1874_CR26","doi-asserted-by":"publisher","first-page":"025713","DOI":"10.1088\/1361-6528\/abb626","volume":"32","author":"A Greene","year":"2021","unstructured":"Greene A, Hashemi J, Kang Y. Development of MnO2 hollow nanoparticles for potential drug delivery applications. Nanotechnology. 2021;32:025713.","journal-title":"Nanotechnology"},{"key":"1874_CR27","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1002\/adma.201305319","volume":"26","author":"Y Li","year":"2014","unstructured":"Li Y, Shi J. Hollow-structured mesoporous materials: chemical synthesis, functionalization and applications. Adv Mater. 2014;26:3176\u2013205.","journal-title":"Adv Mater"},{"key":"1874_CR28","doi-asserted-by":"publisher","first-page":"119405","DOI":"10.1016\/j.biomaterials.2019.119405","volume":"220","author":"Y Wang","year":"2019","unstructured":"Wang Y, Song S, Lu T, Cheng Y, Song Y, Wang S, Tan F, Li J, Li N. Oxygen-supplementing mesoporous polydopamine nanosponges with WS2 QDs-embedded for CT\/MSOT\/MR imaging and thermoradiotherapy of hypoxic cancer. Biomaterials. 2019;220:119405.","journal-title":"Biomaterials"},{"key":"1874_CR29","first-page":"2497","volume":"60","author":"PA Netti","year":"2020","unstructured":"Netti PA, Berk DA, Swartz MA, Grodzinsky AJ, Jain RK. Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res. 2020;60:2497\u2013503.","journal-title":"Cancer Res"},{"key":"1874_CR30","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jconrel.2009.04.010","volume":"138","author":"AS Mikhail","year":"2009","unstructured":"Mikhail AS, Allen C. Block copolymer micelles for delivery of cancer therapy: transport at the whole body, tissue and cellular levels. J Control Release. 2009;138:214\u201323.","journal-title":"J Control Release"},{"key":"1874_CR31","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nrc1893","volume":"6","author":"AI Minchinton","year":"2006","unstructured":"Minchinton AI, Tannock IF. Drug penetration in solid tumours. Nat Rev Cancer. 2006;6:583\u201392.","journal-title":"Nat Rev Cancer"},{"key":"1874_CR32","doi-asserted-by":"publisher","first-page":"e1906745","DOI":"10.1002\/adma.201906745","volume":"32","author":"F Xu","year":"2020","unstructured":"Xu F, Huang X, Wang Y, Zhou S. A size-changeable collagenase-modified nanoscavenger for increasing penetration and retention of nanomedicine in deep tumor tissue. Adv Mater. 2020;32:e1906745.","journal-title":"Adv Mater"},{"key":"1874_CR33","doi-asserted-by":"publisher","first-page":"24075","DOI":"10.1021\/acsami.5b07116","volume":"7","author":"MR Villegas","year":"2015","unstructured":"Villegas MR, Baeza A, Vallet-Regi M. Hybrid collagenase nanocapsules for enhanced nanocarrier penetration in tumoral tissues. ACS Appl Mater Inter. 2015;7:24075\u201381.","journal-title":"ACS Appl Mater Inter"},{"key":"1874_CR34","doi-asserted-by":"publisher","first-page":"20214","DOI":"10.1021\/acsami.0c03022","volume":"12","author":"H Yao","year":"2020","unstructured":"Yao H, Guo X, Zhou H, Ren J, Li Y, Duan S, Gong X, Du B. Mild acid-responsive \u201cnanoenzyme capsule\"remodeling of the tumor microenvironment to increase tumor penetration. ACS Appl Mater Inter. 2020;12:20214\u201327.","journal-title":"ACS Appl Mater Inter"},{"key":"1874_CR35","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1002\/anie.201800511","volume":"57","author":"J Li","year":"2018","unstructured":"Li J, Xie C, Huang J, Jiang Y, Miao Q, Pu K. Semiconducting polymer nanoenzymes with photothermic activity for enhanced cancer therapy. Angew Chem Int Ed Engl. 2018;57:3995\u20138.","journal-title":"Angew Chem Int Ed Engl"},{"key":"1874_CR36","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1126\/science.285.5433.1569","volume":"285","author":"SR Schwarze","year":"1999","unstructured":"Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science. 1999;285:1569\u201372.","journal-title":"Science"},{"key":"1874_CR37","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nnano.2009.341","volume":"5","author":"M Yan","year":"2010","unstructured":"Yan M, Du J, Gu Z, Liang M, Hu Y, Zhang W, Priceman S, Wu L, Zhou ZH, Liu Z, Segura T, Tang Y, Lu Y. A novel intracellular protein delivery platform based on single-protein nanocapsules. Nat Nanotechnol. 2010;5:48\u201353.","journal-title":"Nat Nanotechnol"},{"key":"1874_CR38","doi-asserted-by":"publisher","first-page":"17024","DOI":"10.1038\/natrevmats.2017.24","volume":"2","author":"H Chen","year":"2017","unstructured":"Chen H, Zhang W, Zhu G, Xie J, Chen X. Rethinking cancer nanotheranostics. Nat Rev Mater. 2017;2:17024.","journal-title":"Nat Rev Mater"},{"key":"1874_CR39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12951-019-0513-z","volume":"17","author":"L Qiang","year":"2019","unstructured":"Qiang L, Cai Z, Jiang W, Liu J, Tai Z, Li G, Gong C, Gao S, Gao Y. A novel macrophage-mediated biomimetic delivery system with NIR-triggered release for prostate cancer therapy. J Nanobiotech. 2019;17:83.","journal-title":"J Nanobiotech"},{"key":"1874_CR40","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.7150\/thno.40489","volume":"10","author":"J Chen","year":"2020","unstructured":"Chen J, Wu Z, Ding W, Xiao. C, Zhang Y, Gao S, Gao Y, Cai W. SREBP1 siRNA enhance the docetaxel effect based on a bone-cancer dual-targeting biomimetic nanosystem against bone metastatic castration-resistant prostate cancer. Theranostics. 2020;10:1619\u201332.","journal-title":"Theranostics"},{"key":"1874_CR41","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1021\/acs.accounts.9b00079","volume":"52","author":"Z Chen","year":"2019","unstructured":"Chen Z, Wang Z, Gu Z. Bioinspired and biomimetic nanomedicines. Acc Chem Res. 2019;52:1255\u201364.","journal-title":"Acc Chem Res"},{"key":"1874_CR42","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12951-020-00649-8","volume":"18","author":"C Gong","year":"2020","unstructured":"Gong C, Yu X, You B, Wu Y, Wang R, Han L, Wang Y, Gao S, Yuan Y. Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy. J Nanobiotech. 2020;18:92.","journal-title":"J Nanobiotech"},{"key":"1874_CR43","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1021\/acs.nanolett.7b05263","volume":"18","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Cai K, Li C, Guo Q, Chen Q, He X, Sun T, Huang Y, Cheng J, Jiang C. Macrophage-membrane-coated nanoparticles for tumor-targeted chemotherapy. Nano Lett. 2018;18:1908\u201315.","journal-title":"Nano Lett"},{"key":"1874_CR44","doi-asserted-by":"publisher","first-page":"e1904639","DOI":"10.1002\/adma.201904639","volume":"31","author":"F Gao","year":"2019","unstructured":"Gao F, Tan Y, g, Liu WL, Zou MZ, Huang C, Liu CJ, Zhang XZ. Intra\/extracellular lactic acid exhaustion for synergistic metabolic therapy and immunotherapy of tumors. Adv Mater. 2019;31:e1904639.","journal-title":"Adv Mater"},{"key":"1874_CR45","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/1061186X.2019.1641507","volume":"28","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Wang H, Jia X, Du S, Yin Y, Zhang X. Cascade catalytic nanoplatform for enhanced starvation and sonodynamic therapy. J Drug Target. 2020;28:195\u2013203.","journal-title":"J Drug Target"},{"key":"1874_CR46","doi-asserted-by":"publisher","first-page":"1606209","DOI":"10.1002\/adma.201606209","volume":"29","author":"D Dehaini","year":"2017","unstructured":"Dehaini D, Wei X, Fang RH, Masson S, Angsantikul P, Luk BT, Zhang Y, g Yin M, Jiang Y, Krol AV, Gao W, Zhang L. Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization. Adv Mater. 2017;29:1606209.","journal-title":"Adv Mater"},{"key":"1874_CR47","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.7150\/thno.17908","volume":"7","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Wei J, Liu S, Wang J, Han X, Qin H, Lang J, Cheng K, Li Y, Qi Y, Anderson GJ, Sukumar S, Li S, Nie G. Inhibition of platelet function using liposomal nanoparticles blocks tumor metastasis. Theranostics. 2017;7:1062\u201371.","journal-title":"Theranostics"},{"key":"1874_CR48","doi-asserted-by":"publisher","first-page":"1700640","DOI":"10.1002\/smll.201700640","volume":"13","author":"L Tian","year":"2017","unstructured":"Tian L, Chen Q, Yi X, Chen J, Liang C, Chao Y, Yang K, Liu Z. Albumin-templated anganese dioxide nanoparticles for enhanced radioisotope therapy. Small. 2017;13:1700640.","journal-title":"Small"},{"key":"1874_CR49","doi-asserted-by":"publisher","first-page":"1605985","DOI":"10.1002\/adfm.201605985","volume":"27","author":"X Zeng","year":"2017","unstructured":"Zeng X, Liu G, Tao W, Ma Y, Zhang X, He F, Pan J, Mei L, Pan G. A drug-self-gated mesoporous antitumor nanoplatform based on pH-sensitive dynamic covalent bond. Adv Funct. 2017;27:1605985.","journal-title":"Adv Funct"},{"key":"1874_CR50","doi-asserted-by":"publisher","first-page":"119374","DOI":"10.1016\/j.biomaterials.2019.119374","volume":"2219","author":"C Dai","year":"2019","unstructured":"Dai C, Wang C, Hu R, Lin H, Liu Z, Yu L, Chen Y, Zhang B. Photonic\/magnetic hyperthermia-synergistic nanocatalytic cancer therapy enabled by zero-valence iron nanocatalysts. Biomaterials. 2019;2219:119374.","journal-title":"Biomaterials"},{"key":"1874_CR51","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.biomaterials.2018.09.023","volume":"186","author":"JJ Arroyo-Crespo","year":"2018","unstructured":"Arroyo-Crespo JJ, Arminan A, Charbonnier D, Balzano-Nogueira L, Huertas-Lopez F, Marti C, Tarazona S, Forteza J, Conesa A, Vicent MJ. Tumor microenvironment-targeted poly-L-glutamic acid-based combination conjugate for enhanced triple negative breast cancer treatment. Biomaterials. 2018;186:8\u201321.","journal-title":"Biomaterials"},{"key":"1874_CR52","doi-asserted-by":"publisher","first-page":"4947","DOI":"10.1039\/C7PY00559H","volume":"8","author":"G Lazzari","year":"2017","unstructured":"Lazzari G, Couvreur P, Mura S. Multicellular tumor spheroids: a relevant 3D model for the in vitro preclinical investigation of polymer nanomedicines. Polym Chem. 2017;8:4947.","journal-title":"Polym Chem"},{"key":"1874_CR53","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1039\/C9NR09572A","volume":"12","author":"MS Singh","year":"2020","unstructured":"Singh MS, Goldsmith M, Thakur K, Chatterjee S, Landesman-Milo D, Levy T, Kunz-Schughart LA, Barenholzk Y, Peer D. An ovarian spheroid based tumor model that represents vascularized tumors and enables the investigation of nanomedicine therapeutics. Nanoscale. 2020;12:1894\u2013903.","journal-title":"Nanoscale"},{"key":"1874_CR54","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/bit.26845","volume":"116","author":"AS Nunes","year":"2019","unstructured":"Nunes AS, Barros AS, Costa EC, Moreira AF, Correia IJ. 3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs. Biotechnol Bioeng. 2019;116:206\u201326.","journal-title":"Biotechnol Bioeng"},{"key":"1874_CR55","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/nnano.2011.166","volume":"6","author":"H Cabral","year":"2011","unstructured":"Cabral H, Matsumoto Y, Mizuno K, Chen Q, Murakami M, Kimura M, Uesaka M, Nishiyama N. Kataoka K., Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat Nanotechnol. 2011;6:815\u201323.","journal-title":"Nat Nanotechnol"},{"key":"1874_CR56","doi-asserted-by":"publisher","first-page":"110337","DOI":"10.1016\/j.eurpolymj.2021.110337","volume":"147","author":"KL Swetha","year":"2021","unstructured":"Swetha KL, Maravajjala KS, Sharma S, Chowdhury R, Roy A. Development of a tumor extracellular pH-responsive nanocarrier by terminal histidine conjugation in a star shaped poly(lactic-co-glycolic acid). Eur Polym J. 2021;147:110337.","journal-title":"Eur Polym J"},{"key":"1874_CR57","doi-asserted-by":"publisher","first-page":"6458","DOI":"10.1021\/acsnano.8b02881","volume":"12","author":"F Meng","year":"2018","unstructured":"Meng F, Wang J, Ping Q, Yeo Y. Quantitative Assessment of nanoparticle biodistribution by fluorescence imaging, revisited. ACS Nano. 2018;12:6458\u201368.","journal-title":"ACS Nano"},{"key":"1874_CR58","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1046\/j.1563-258X.2002.02032.x","volume":"152","author":"P Vaupel","year":"2002","unstructured":"Vaupel P, Briest S, H\u00f6ckel M. Hypoxia in breast cancer: pathogenesis, characterization and biological\/therapeutic implications. Wien Med Wochenschr. 2002;152:334\u201342.","journal-title":"Wien Med Wochenschr"},{"key":"1874_CR59","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41467-017-01050-0","volume":"8","author":"G Yang","year":"2017","unstructured":"Yang G, Xu L, Chao Y, Xu J, Sun X, Wu Y, Peng R, Liu Z. Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses. Nat Commun. 2017;8:902.","journal-title":"Nat Commun"},{"key":"1874_CR60","doi-asserted-by":"publisher","first-page":"7006","DOI":"10.1021\/acsnano.7b02533","volume":"11","author":"S Li","year":"2017","unstructured":"Li S, Cheng H, Xie B, Qiu W, Zeng J, Li C, Liu ZhangL, Zhang W. Cancer cell membrane camouflaged cascade bioreactor for cancer targeted starvation and photodynamic therapy. ACS Nano. 2017;11:7006\u201318.","journal-title":"ACS Nano"},{"key":"1874_CR61","doi-asserted-by":"publisher","first-page":"e1900795","DOI":"10.1002\/adma.201900795","volume":"31","author":"G Liu","year":"2019","unstructured":"Liu G, Zhao X, Zhang Y, Xu J, Xu J, Li Y, Min H, Shi J, Zhao Y, Wei J, Wang J, Nie G. Engineering biomimetic platesomes for pH-responsive drug delivery and enhanced antitumor activity. Adv Mater. 2019;31:e1900795.","journal-title":"Adv Mater"},{"key":"1874_CR62","doi-asserted-by":"publisher","first-page":"2003679","DOI":"10.1002\/advs.202003679","volume":"8","author":"X Liu","year":"2021","unstructured":"Liu X, Dong X, Yang S, Lai X, Liu H, Gao Y, Feng H, Zhu M, Yuan Y, Lu Q, Lovell JF, Chen H, Fang C. Biomimetic liposomal nanoplatinum for targeted cancer chemophototherapy. Adv Sci. 2021;8:2003679.","journal-title":"Adv Sci"},{"key":"1874_CR63","doi-asserted-by":"publisher","first-page":"1604258","DOI":"10.1002\/adfm.201604258","volume":"27","author":"Z Ma","year":"2017","unstructured":"Ma Z, Jia X, Bai J, Ruan Y, Wang C, Li J, Zhang M, Jiang X. MnO2 gatekeeper: an intelligent and O2-evolving shell for preventing premature release of high cargo payload core, overcoming tumor hypoxia, and acidic H2O2\u2010sensitive MRI. Adv Func. 2017;27:1604258.","journal-title":"Adv Func"},{"key":"1874_CR64","first-page":"3639","volume":"37","author":"JM Yuhas","year":"1977","unstructured":"Yuhas JM, Li AP, Martinez AO, Ladman AJ. A simplified method for production and growth of multicellular tumor spheroids. Cancer Res. 1977;37:3639\u201343.","journal-title":"Cancer Res"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-01874-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-023-01874-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-01874-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T05:03:29Z","timestamp":1681103009000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-023-01874-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,10]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1874"],"URL":"https:\/\/doi.org\/10.1186\/s12951-023-01874-7","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,10]]},"assertion":[{"value":"14 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experiments were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publication No. 8023, revised 1978) and were approved by the Research Center for Laboratory Animals of the Fudan Unversity (Shanghai, China).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There is no conflict of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"123"}}